Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $64.88 ($25,952)
  2. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $61.37 ($24,548)
  3. 4 Grant or award Director acquired 4,336 shares (grant or award)
  4. 4 Grant or award Director acquired 4,336 shares (grant or award)
  5. 4 Grant or award Director acquired 4,336 shares (grant or award)
  6. 4 Grant or award Director acquired 4,336 shares (grant or award)
  7. 4 Grant or award Director acquired 4,336 shares (grant or award)
  8. 4 Grant or award Director acquired 4,336 shares (grant or award)
  9. 4 Open-market sale SVP, GENERICS sold 881 shares at $60.07 ($52,922)
  10. 4 Open-market sale HEAD OF RARE DISEASE sold 4,000 shares at $60.45 ($241,800)
  11. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $62.20 ($24,880)
  12. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 700 shares at $76.83 ($53,781)
  13. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $68.96 ($27,584)
  14. 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,455 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP & CFO gave up 6,210 shares (to pay taxes)
  16. 4 Planned sale SVP, CHIEF HR OFFICER sold 1,866 shares at $65.00 ($121,290)
  17. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $63.33 ($25,332)
  18. 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 2,874 shares (to pay taxes)
  19. 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,060 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, GENERICS gave up 3,314 shares (to pay taxes)

Page 6 of 42 · 834 filings